Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.735 USD | +7.60% | -2.10% | -47.87% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- MarketScreener Editorial Features